ORCA-3 Phase 3 Trial Reports Statistically Significant Topline Efficacy Results in Smoking Cessation
Firm | Analyst |
---|---|
Alliance Global Partners | James Molloy |
H.C. Wainwright & Co. | Vernon Bernardino |
Ladenburg Thalmann | Michael Higgins |
Lake Street Capital | Thomas Flaten |
Maxim Group | Jason McCarthy |
Oppenheimer | Francois Brisebois |
Zacks | John Vandermosten |
Achieve Life Sciences, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Achieve Life Sciences, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Achieve Life Sciences, Inc. or its management. Achieve Life Sciences, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.